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Abstract 
Anxiety disorders are a major public health problem, and a range of wearable 
technological devices for addressing the somatic symptoms of anxiety are increasingly available.  
This narrative review summarises five distinct modalities underlying wearable devices and 
investigates clinical implications for managing clients using such devices.  The literature 
suggests potential benefits of HRV biofeedback devices, whilst other modalities (aided 
meditation, false physiological feedback, electrodermal biofeedback and respiration biofeedback) 
are less supported. High-quality research on the efficacy of such devices is also lacking, 
particularly in clinical populations. Wearables could offer potential benefits, but may be 
contraindicated in some cases. Collaborative use of clinical evaluation tools, such as the 
American Psychiatric Association’s app evaluation model, can aid in shared decision-making 
about device use.  
 
Keywords:  Anxiety; Anxiety Disorders; Biofeedback; Clinical Decision-Making; 
Neurofeedback; Wearable Electronic Devices  
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Wearable Devices as Adjuncts in the Treatment and Management  
of Anxiety-Related Symptoms: A Narrative Review  
of Five Device Modalities and Implications for Clinical Practice 
Anxiety disorders are a major public health concern, with a lifetime prevalence rate 
estimated to be 16.6% globally (Somers, Goldner, Waraich, & Hsu, 2006).  After depressive 
disorders, anxiety disorders carry the greatest disease burden of the mental disorders (Abajobir et 
al., 2017).  Yet despite longstanding recognition of the treatment gap in mental health, and 
substantial increases in the size of the mental health workforce and related government funding, 
the evidence suggests that the prevalence of anxiety-related complaints continues to increase, 
even in developed nations (Jorm, Patten, Brugha, & Mojtabai, 2017).  Furthermore, of those who 
seek help for mood and anxiety disorders, only 26% receive an evidence-based treatment (Jorm 
et al., 2017).  While early technological mental health interventions have shown some promise 
for scaling up treatments (e.g., O’Connor, Munnelly, Whelan, & McHugh, 2017), a new 
generation of consumer-targeted wearable electronic solutions that present new possibilities and 
challenges in addressing anxiety are now becoming available. 
Wearables are interactive computing devices, worn either as an item of clothing or as an 
accessory, and they are an important element of the new frontier of healthcare innovation (Nasir 
& Yurder, 2015).  Wearables, like mobile technologies for health (mHealth), are part of a broader 
movement to democratise healthcare, potentially enabling ubiquitous, patient-centred health 
provision.  With smartphones acting as an “extension of the self” (Morris & Aguilera, 2012, p. 
622), it has been argued that there is promise for improving access, uptake, adherence and 
engagement with treatments, as well as potentially enabling clients to continually manage their 
condition outside of treatment, resulting in reduced costs and better outcomes (Clough & Casey, 
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2015).  Products like smart watches or fitness bands, usually paired with smartphone applications 
(‘apps’), have already been widely adopted in the move towards a “quantified self”: increased 
self-understanding based on personal analytics (Piwek, Ellis, Andrews, & Joinson, 2016).  Now, 
a first generation of wearable devices for addressing mental wellbeing are moving beyond 
quantification with the promise of an “augmented self”, including EEG headbands to aid 
meditation, sensors that provide feedback on irregular or adaptive breathing patterns, and heart 
rate variability monitors that seek to achieve coherence of cardiac and respiratory rhythms.   
A common theme across most of these devices is that they provide some form of 
relaxation training, by giving the wearer an indication of their degree of arousal and guiding 
them in exercises to achieve calm.  Some devices are designed for short session-based use, while 
others are intended to be worn all day, providing moment-to-moment feedback to the user as 
required (so-called ecological momentary interventions).  It has been proposed that wearable 
devices could help to reduce various access barriers by avoiding the need to attend a clinic in 
some cases (Lui, Marcus, & Barry, 2017), and their deployment on a large scale might even 
contribute to the collection of field data that can answer difficult research questions, given 
appropriate user consent (Moraveji, 2012).  The use of mHealth platforms may allow for these 
wearable interventions to be more seamlessly integrated into everyday life, and regular use might 
be encouraged through gamification (Deterding, O’Hara, Sicart, Dixon, & Nacke, 2011; Fleming 
et al., 2016).  Technological delivery could also mean that treatments are more consistently 
applied, compared to provider delivery (Riley, 2017).  Of course, many of these potential 
benefits remain hypothetical for now, since there has been little research on the actual 
acceptability of wearable devices, while research into other e-mental health interventions 
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suggests that widespread adoption has not yet been achieved, despite there being evidence for the 
efficacy of some of these treatments (Apolinário-Hagen, Kemper, & Stürmer, 2017).  
Wearable devices may be particularly suitable for tackling anxiety because somatic 
symptoms are a significant feature of various anxiety disorders, and many of these symptoms 
relate to over-activation of the sympathetic nervous system and corresponding under-activation 
of the parasympathetic nervous system (Friedman, 2007; Mallorquí-Bagué, Bulbena, Pailhez, 
Garfinkel, & Critchley, 2016).  Practice with calming technologies might therefore help to 
increase self-efficacy, reduce aversive interpretations of somatic arousal (Meuret, Wilhelm, & 
Roth, 2004), or even lead to lasting physiological changes (for example, improved baroreflex 
function; Lehrer et al., 2003).  Relaxation techniques already have an established place in the 
treatment of anxiety disorders (Manzoni, Pagnini, Castelnuovo, & Molinari, 2008), but given the 
rapid development and commercialisation of wearables, little knowledge has been generated thus 
far about whether they could facilitate this approach to treatment (Coffey & Coffey, 2016).  
Nonetheless, despite the lack of existing evidence, numerous online reviews and opinion pieces 
offer enthusiastic endorsement for the use of these devices in improving wellbeing and 
addressing clinical disorders such as anxiety.  At the same time, strong growth in annual sales of 
wearable devices is projected to continue over coming years (CCS Insight, 2017).  As with the 
proliferation of smartphone apps, the growing number of wearables presents a challenge for 
clinicians in terms of being able to provide up-to-date advice to clients who may be eager to use 
such technologies.   
In the present review, we aimed to describe the range of modalities through which 
wearables ostensibly address anxiety, highlight some of the available evidence for those 
modalities and for specific devices, and summarise some of the potential implications of using 
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wearables in a clinical context. Importantly, given the broad nature of this issue in terms of the 
range of technologies available, their mechanisms of action, and the generally limited research 
material available, a systematic review was not considered appropriate. Instead, we undertook a 
narrative review to capture the diversity of devices and evidence available in one article (Dijkers, 
2009).  
In order to determine relevant devices for inclusion herein, literature and broader Internet 
searches were conducted using search terms such as “wearable device” or the name of specific 
device modalities once these had been identified.  For inclusion, devices needed to (i) be 
currently available direct to consumers, (ii) cost less than USD $500, (iii) comprise active 
intervention elements using physiological or neurological signals, and (iv) be oriented toward 
consumer use rather than research or specialised applications unrelated to anxiety symptoms.  A 
total of 40 devices were identified, with 26 devices being excluded (research/specialised 
orientation: 11, no active intervention elements: 9, not presently available for purchase: 4, cost: 
1, not wearable: 1). The remaining 14 devices (Table 1) were then grouped according to their 
assumed modalities.  Each of these modalities is further described below, and, where available, 
the results of recent systematic reviews evaluating the evidence for each modality are 
summarised.  Furthermore, where literature that specifically evaluated the identified devices 
could be found, it is also reviewed here.  Following this discussion of different device modalities, 
the clinical implications of using these devices—including risks and unexpected effects, as well 
as approaches for clinical evaluation—are considered.  
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Device Modalities 
Heart rate variability biofeedback 
Many of the wearable devices for anxiety identified in this review ostensibly operate 
through biofeedback.  Biofeedback training devices are thought to work by feeding back 
information about bodily signals to allow trainees to recognise and learn to control those signals.  
While early biofeedback research tended to focus on parameters such as skin temperature, heart 
rate and muscle potential, recent devices have been developed around bodily signals that require 
more sophisticated measurement and/or interpretation, such as heart rate variability, 
electrodermal activity, respiration and EEG (Schoenberg & David, 2014).  Heart rate variability 
(HRV) is the variation in interval between heartbeats.  It is an important signal because it has 
been shown to be a reliable predictor of physical health as well as an indicator of healthy 
parasympathetic functioning, which is associated with the ability to self-regulate emotions under 
stress (Caldwell & Steffen, 2018; Goessl, Curtiss, & Hofmann, 2017; Jester, Rozek, & McKelley, 
2018).  It is perhaps unsurprising, then, that reduced HRV has been observed in most types of 
anxiety disorder (Chalmers, Quintana, Abbott, & Kemp, 2014).  HRV is influenced in large part 
by respiratory sinus arrhythmia, whereby heart rate accelerates during inhalation and decelerates 
during exhalation (Goessl et al., 2017).  HRV biofeedback aims to maximize HRV by guiding 
trainees in breathing at their “resonance rate”—the number of breaths per minute that produces 
the largest variability in heart rate, usually around six—through feeding back information about 
their HRV (Kleen & Reitsma, 2011).  The resonance rate causes maximal heart rate oscillation as 
a result of heart rate becoming in phase with breathing and out of phase with blood pressure 
oscillations (Lehrer & Gevirtz, 2014). 
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Individual HRV biofeedback devices may operate in slightly different ways, but they 
generally work by giving paced breathing cues while also displaying feedback about the level of 
coherence being achieved between heart rate and breathing.  The range of available HRV devices 
are perhaps the most developed in terms of wearables for mental health.  This may be in part 
because unlike most other wearables, non-proprietary communication protocols used by many 
HRV sensors mean that apps can connect with a range of different sensors, and vice versa.  
Perhaps for this reason, some HRV solutions can appear economical when compared to other 
wearables.  Sensors come in multiple forms, from chest straps to optical ear or finger clip 
sensors.  Future apps may even utilise the smartphone camera as a photoplethysmographic heart 
rate sensor, allowing for HRV to be trained without the use of an additional measuring device, 
and this technique has been shown to produce valid measurements (Plews et al., 2017).  Some of 
the products on the market are entirely integrated offerings, which function either as standalone 
devices (e.g. HeartMath emWave 2) or as a paired sensor and smartphone app (e.g. HeartMath 
Inner Balance).  HRV measurement is also incorporated into many recent fitness watch products 
such as some FitBit and Garmin devices, as well as the Apple Watch.  However, these watch 
implementations are typically not compatible with standard communication protocols, meaning 
that only proprietary software can be used, and this often does not feature biofeedback options, 
but is used instead for quantifying fitness levels.  Furthermore, the sensors used in wrist-worn 
devices can be prone to artefacts, and so accurate readings may only be produced when 
completely still (Baek & Shin, 2017). 
Support for HRV biofeedback. A recent meta-analysis of 24 RCTs targeting stress and 
anxiety in clinical and non-clinical populations revealed large effects for HRV biofeedback 
overall, both within groups and when compared to a mix of passive and active controls (Goessl 
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et al., 2017).  However, the authors of that review identified an unclear risk of study bias 
(according to Cochrane Handbook guidelines) in the majority of included studies, such that sub-
optimal randomisation, blinding, and treatment of missing data may compromise the fidelity of 
the results.  While Goessl et al. attempted to evaluate the impact of study bias with a moderation 
analysis, the non-significant results of this analysis cannot be interpreted for the intended 
purpose because only studies with a high or unclear overall risk of bias were included.   Schmidt 
and Martin (2017) carried out a further qualitative systematic review of 21 RCTs using HRV 
biofeedback for physical and psychological problems, finding that increases in HRV were 
persistent, and effects on psychological variables like subjective stress were positive but 
generally not superior to active controls.  However, they also note a lack of controlled studies 
showing effects of HRV biofeedback on psychological outcomes.  Both reviews thus 
demonstrate that potential study bias is a major limitation of the evidence available at present.  A 
second major issue is that few studies identified in these systematic reviews compared HRV 
biofeedback with active controls in clinical populations.  This represents a significant concern for 
clinicians, who need to know whether a proposed intervention is likely to be at least as effective 
as current best practices for the treatment of a specific disorder or symptom cluster.   Other 
limitations of existing research include a failure to observe a dose-response relationship in many 
studies, as well as differences in treatment protocols between studies.  Most outcome measures 
rely on self-report, although physiological and neurological changes have also been observed, 
indicating that outcomes are not limited to subjective measures (Lehrer et al., 2003; Prinsloo, 
Rauch, Karpul, & Derman, 2013).  Lastly, the long-term benefits of treatment, including how 
measured improvements translate into everyday coping, have not been well explored as yet 
(Wheat & Larkin, 2010).  In summary, while recent systematic reviews suggest that HRV 
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biofeedback could lead to clinically significant improvements for people with anxiety through 
increased self-awareness and improved physiological and psychological self-regulation, higher 
quality research, and particularly studies within clinical populations that compare against active 
control treatments, are needed to further substantiate these claims (Goessl, Curtiss, & Hofmann, 
2017; Schmidt & Martin, 2017).  Since much of the research in these reviews was done with 
research-grade equipment, and given the difficulty in measuring HRV accurately, more evidence 
is also needed to show that these treatments can be effectively reproduced in consumer-grade 
wearable technology.  
Respiration biofeedback 
Another bodily signal targeted by biofeedback devices is respiration.  The dynamic two-
way relationship between breathing patterns and affective state has already been well established 
(Ley, 1999).  While stress may lead to hyperventilation—depending on the intensity of the 
stressor and the learned reactivity to stress—respiratory rate can also be controlled volitionally, 
and is therefore a potential therapeutic target (Moraveji, 2012).  Irregularities in baseline 
respiratory rate have been observed in some diagnoses of anxiety (Grassi et al., 2014).  
Furthermore, a decreased baseline respiratory rate has been observed following clinical 
interventions like meditation (Pascoe, Thompson, Jenkins, & Ski, 2017).  Acknowledging this 
connection, breathing training has been used as an effective clinical treatment, sometimes aided 
by feeding back information about respiratory parameters to trainees (Meuret, Wilhelm, & Roth, 
2004).  When combined, respiratory features such as breath rate, inhalation-exhalation ratio and 
tidal volume can discriminate stress with a similar level of power to ECG features, and closely 
predict self-reported measures of perceived stress in ecologically valid scenarios (Plarre et al., 
2011).  However, consistently monitoring the breath during everyday life is challenging as 
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constant attention is required, and respiratory patterns therefore represent a potential target for 
intervention with wearable devices.  
Perhaps the first mass-market wearable device based on respiratory activity is the Stone 
(Spire, Inc), a small sensor that is attached to the belt or underwear.  This device registers 
breathing patterns and categorises the user’s state as normal, calm, tense, or focused.  It can send 
alerts to the wearer when changes in breath indicate a rise in tension, and gives positive feedback 
when users achieve an extended period of calm.  Guided meditations with respiratory feedback 
are also available on demand through the app.   
Support for respiration biofeedback. To date, there appears to be little evidence around 
the effectiveness of respiration biofeedback.  A recent systematic review of multiple biofeedback 
modalities identified only three studies where respiration biofeedback was used, all of which 
were for treatment of panic disorder, with only one study reporting statistically significant 
symptomatic change (Schoenberg & David, 2014).  However, the treatments used in these 
studies were fundamentally quite different to that of devices that provide ecological momentary 
interventions based on respiratory features, such as the Stone, making it difficult to translate any 
conclusions.  Little research evaluating such devices appears to be have been conducted thus far.  
An unpublished study conducted by Spire in partnership with Stanford University and LinkedIn 
engaged 225 LinkedIn employees, around half of whom received a Stone device and used it over 
a one-month period (Moraveji et al., 2017).  Compared to the group who did not receive a 
device, users demonstrated significant decreases in measures of anxiety, negative affect and 
perceived stress.  While the amount of time spent in a ‘calm’ state (as classified by the device) 
increased by 37% on average over the course of the study, high variability between participants 
meant that this change was not statistically significant.  The study’s conclusions should be 
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considered with caution since it was not subjected to peer review, and the open-label nature of 
the trial means that expectancy effects were not controlled for.  Furthermore, the participants did 
not represent a well-defined clinical population, and a 41% drop-out rate in the treatment group 
suggests that uptake of the device among users may be problematic. 
Electrodermal activity biofeedback 
Electrodermal activity (EDA), also known as galvanic skin response, refers to the 
changes in conductance of the skin due to sweat glands being activated by the sympathetic 
nervous system (Parnandi & Gutierrez-Osuna, 2017).  Changes in EDA are associated both with 
neural measures of arousal (Critchley, Eccles, & Garfinkel, 2013) and with psychological stress 
(Salafi & Kah, 2015; Visnovcova, Mestanik, Gala, Mestanikova, & Tonhajzerova, 2016).  There 
are two primary characteristics of EDA: skin conductance level (SCL) is a baseline measure of 
sympathetic arousal, while skin conductance response (SCR) refers to momentary peaks in the 
signal which occur in response to episodic stressors such as startle events or affective arousal 
(Parnandi & Gutierrez-Osuna, 2017).  Only one consumer-grade EDA biofeedback device was 
identified in the present review.  The Pip (Galvanic Ltd) is a small device that is held between the 
thumb and forefinger, and it can be used with a number of included game-based apps in which 
the user makes progress toward goals by reducing their level of arousal.   
Support for EDA biofeedback. Despite research showing the link with objective and 
subjective measures of arousal, a recent systematic review found a lack of quality evidence for 
the efficacy of EDA biofeedback for any mental disorder thus far (Schoenberg & David, 2014).  
Only one study evaluating an EDA-based wearable device could be identified, trialling the Pip in 
a group of healthy participants using game-based apps following a stress induction two after  
(Dillon, Kelly, Robertson, & Robertson, 2016).  Compared to the control group who played a 
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game without biofeedback, participants using the Pip reported significantly lower heart rate and 
perceived stress.  However, the observed effect size was small, and longer-term effects were not 
studied. Further studies therefore appear to be required in order to establish the credibility of this 
form of treatment, particularly with regard to anxiety disorders. 
 
Neurofeedback and aided meditation 
Neurofeedback, also known as EEG biofeedback, is a specific form of biofeedback that 
works by giving users information regarding characteristics of the EEG signal measured over 
particular cortical regions (Demos, 2005).  For some decades, neurofeedback has been used 
clinically to treat conditions such as attention disorders and epilepsy (Kopřivová et al., 2013).  
Neurotherapy typically involves taking quantitative EEG data which can be compared to 
normative data to identify cortical regions that are under- or over-active within specific 
frequency bands, after which neurofeedback protocols can be developed to reward normalisation 
of brain activity in these areas (Demos, 2005).  Consumer-grade neurofeedback devices operate 
in a simpler way, often only having active sensors in the prefrontal area where hair does not 
preclude the use of dry electrodes.  These devices typically have a range of manufacturer and/or 
third-party apps which function in various ways.  Some apps simply quantify EEG state, while 
others attempt to infer associated mental state (e.g. focused, tense, relaxed), or include games 
where the objective is for the user to perform increasingly difficult tasks while controlling their 
level of arousal.  However, the specific EEG patterns being targeted by these apps are often not 
disclosed, making it difficult to make any generalisations about the efficacy of treatments using 
this modality. 
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One specific way that neurofeedback might be used to improve mental health is through 
aiding meditation.  Meditation-based interventions have been associated with significant 
reductions in physiological signs of stress, such as cortisol, blood pressure and heart rate (Pascoe 
et al., 2017).  Limited early evidence suggests that mindfulness programs incorporating 
meditation could be comparable to gold-standard cognitive behavioural interventions when used 
to treat anxiety disorders (Singh & Gorey, 2017), although more research is needed to 
comprehensively address this question.  Furthermore, stand-alone (i.e., used in isolation from 
other treatment) mindfulness exercises such as guided breathing meditation have been shown to 
have small-to-moderate effects on anxiety compared with stand-alone active controls (Blanck et 
al., 2018).  Aided meditation employs algorithms that process EEG signals to detect mind-
wandering, which has been associated with gamma power in the posterior cingulate cortex (van 
Lutterveld et al., 2017) and with theta power globally (Braboszcz & Delorme, 2011).  Auditory 
or visual feedback can then be given to the user, for example by increasing the volume of 
background sounds to signal the mind becoming distracted.  Because meditation can be difficult 
to learn, neurofeedback may help the learning process by giving objective feedback (van 
Lutterveld et al., 2017).  Moreover, some clients feel they are “doing nothing” during meditation 
or that the instructions are ambiguous (Kleen & Reitsma, 2011), and real-time feedback based on 
cortical activity could overcome this problem.  It should be noted that current implementations of 
aided meditation tend to be developed specifically for use with concentrative meditation, such as 
focusing on the breath, but may not necessarily support other meditative approaches such as 
mindfully being aware and accepting of all thoughts and feelings. 
Support for assisted meditation. Few studies have assessed the efficacy of 
neurofeedback-assisted meditation devices, perhaps because of their relatively recent inception.  
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Several recent trials have evaluated the use of the Muse headband relative to similarly structured 
active controls in short (4-6 week) interventions (Balconi, Fronda, & Crivelli, 2018; Balconi, 
Fronda, Venturella, & Crivelli, 2017; Bhayee et al., 2016; Crivelli, Fronda, Venturella, & 
Balconi, 2018).  The results of this early research suggest that compared to controls, regular use 
of Muse could lead to significant improvements in outcomes such as somatic symptoms, 
perceived stress, state anxiety, and mood modulation in healthy or moderately stressed adults.  
Crivelli et al. (2018) also reported significant changes in objective measures such as a reaction 
time task, N2 event-related potentials, and associated EEG measures.  Preliminary results of 
another trial involving people with a mild-to-moderate traumatic brain injury suggest 
improvements in anxiety and depression symptoms, as well as measures of self-efficacy and 
mindfulness, although full analyses from this study are yet to be reported (Gray, 2017).  
Importantly, no published studies using participants with anxiety or other psychological disorders 
were identified and thus, the efficacy of such devices in clinical populations remains entirely 
unknown.   
Entrainment and false feedback 
Another mechanism through which wearable devices can operate is entrainment.  
Entrainment is the synchronisation of one’s brain or body with rhythmic stimuli found in the 
environment, either voluntarily or involuntarily (Ross & Balasubramaniam, 2014).  Unlike 
biofeedback, entrainment does not rely on learning or even on paying attention to a stimulus, but 
can occur merely through exposure.  For example, heart rate and respiration rate tend to be 
entrained by music, relative to the tempo (Larsen & Galletly, 2006).  In false feedback 
approaches, a signal is provided which explicitly mimics a natural physiological rhythm, such as 
heart rate.  This type of feedback may alter the perception of emotional arousal, including both 
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positive and negative affect (Crucian et al., 2000).  Entrainment and false feedback technologies 
offer interesting avenues for exploration because they may have the potential to aid emotional 
regulation with no effort required from the user, reducing problems of compliance, and avoiding 
the possibility that managing the device itself will become an added stressor for the user (Costa, 
Adams, Jung, Guimbretierè, & Choudhury, 2016).   
Support for false feedback. The entrainment of neural rhythms (brainwave entrainment) 
has already received much attention from both researchers and consumers, and due to the fact 
that such devices are not novel, they will not be further explored here.  However, recent research 
has also explored the potential for entraining other physiological characteristics through 
wearable devices.  Costa et al. (2016) developed a prototype wristband device to deliver a 
heartbeat-like vibration at a consistent low tempo where the pulse is normally felt.  Under 
induced stress, users who were told the device fed back their heart rate had a significantly lower 
increase in state/trait anxiety relative to the control group, who wore the device switched off.  A 
third group who had the device switched on, but were told only that it created a vibration, did not 
differ significantly from the control group.  These results suggest that the perception of the 
truthfulness of feedback is important.  However, Azevedo et al. (2017) found different effects 
with the doppel—a very similar commercially available device—under comparable conditions.  
Here, participants who had the device switched on demonstrated an objectively and subjectively 
reduced stress response, even though they were told that it was simply a measuring instrument.  
While these early studies show promise, physiological entrainment needs to be researched much 
more thoroughly in order to answer the outstanding questions and generate sufficient evidence to 
warrant its use, particularly in clinical populations. 
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Clinical Implications 
 As with many new or alternative therapies there is a growing interest in using wearable 
devices for mental health, however this has not been matched with adequate supporting 
evidence.  In particular, researchers have not yet investigated whether any of the wearable 
devices identified in this review are effective for people experiencing clinically significant 
anxiety symptoms.  This is a substantial limitation given that evidence-based approaches 
emphasise the importance of appropriate evidence being applicable to the specific patient or 
problem at hand (Gillam & Siriwardena, 2014).  Nevertheless, failing to fully engage with clients 
who intend to use wearables as part of their treatment might lead to those clients seeking help 
elsewhere, or worse still, not at all (Coffey & Coffey, 2016).  If nothing else, the use of 
wearables as an adjunct to therapy may potentially help through expectancy effects and increased 
engagement.  Several devices also offer online practitioner portals which allow clinicians to 
monitor the data generated by the client’s devices, given their consent—a feature which may be 
useful in monitoring progress, increasing adherence, and potentially in providing useful 
diagnostic information. 
Risks and unexpected effects 
Little research has explored the implications of using biofeedback devices as an adjunct 
to therapy, although potential side effects such as fatigue and dizziness have been identified 
(Clough & Casey, 2011).  For aided meditation, existing contraindications for meditative 
therapies might be considered, such as a history of trauma, psychosis, mania, suicidality, or 
seizures (Lustyk, Chawla, Nolan, & Marlatt, 2009).  Anxiety about technology could mean that 
for some clients, attempts to use wearables exacerbates the very issue they try to address 
(Laxman, Krishnan, & Dhillon, 2015).  It has also been suggested that relaxation techniques may 
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become counterproductive to therapeutic objectives if they begin to be used as a strategy to avoid 
unpleasant emotions rather than allowing them to be experienced (Allen, McHugh, & Barlow, 
2007).  
Cuijpers and Schuurmans (2007) report that self-help interventions, including relaxation 
techniques, are particularly useful in overcoming client barriers such as cost, distance and an 
anxiety of traditional mental health settings.  However, the use of self-help interventions without 
sufficient professional guidance was a concern due to the possibility of misdiagnosis and the 
greater likelihood of early dropout.  Evidence-based interventions could be iatrogenic if they are 
poorly implemented technologically, leading to no improvement and thereby reinforcing 
treatment avoidance (Torous, Levin, Ahern, & Oser, 2017).  Concerns have also been expressed 
about whether the use of technology may compromise the therapeutic alliance, although there is 
some evidence for the opposite, at least where technology is used appropriately according to 
client preferences (Richards, Simpson, Bastiampillai, Pietrabissa, & Castelnuovo, 2016).  
Furthermore, the use of mHealth technologies may be unsuited to clients who are at significant 
safety risk, and may cause unnecessary complications in complex therapeutic cases (Torous & 
Roberts, 2017). 
Clinicians can educate clients about the fact that not all treatment approaches are 
beneficial for every person, and help them to understand the potential risk of iatrogenic effects.  
For some clients, an over-reliance on the information provided by devices could be a concern: 
one report indicates that clients may become fixated on wearable device data—which may be 
limited in accuracy and scope—resulting in the therapeutic relationship being compromised 
(Baron, Abbott, Jao, Manalo, & Mullen, 2017).  It may therefore be important to emphasise to 
some clients that wearables are only one piece of the larger treatment picture, and to have an 
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open discussion about the limitations to the validity and effectiveness of such devices.  On the 
other hand, perceptions of limited treatment efficacy may increase the risk of premature 
termination of therapy (Mojtabai et al., 2012), so having an overly negative attitude about 
wearables may become a self-fulfilling prophesy.  
Clinical evaluation of devices 
While Clough and Casey (2015) contend that practitioners need to be familiar with 
mHealth technologies in order to effectively guide clients, Morris and Aguilera (2012) instead 
see the client as taking ownership, with clinicians guiding the discussion about how devices are 
being used and adding value to the treatment.  Asking the client to demonstrate the use of the 
device may however be helpful in beginning a dialogue about possible risks and benefits, and 
about how use of the device might play a role in the treatment (Torous & Roberts, 2017).  
Because new wearables are constantly being developed, it may be almost impossible for 
practitioners to stay abreast of individual devices.  Moreover, the information that manufacturers 
openly provide about the functionality of their devices and their scientific validity is often 
lacking.  Having a basic understanding of the various modalities through which devices operate, 
as discussed in this review, may aid in navigating this new landscape and in providing guidance 
to clients.  Nonetheless, treatment benefits may vary depending on the fidelity with which the 
treatment is implemented within each particular device.  Much of the supporting evidence for 
particular modalities (in particular, HRV) is based on the use of research-grade equipment, and 
this raises questions over whether such treatments can be reproduced in much less robust 
consumer-grade devices.  Furthermore, it is likely that other factors such as device design and 
usability could have a substantial effect on treatment outcomes. 
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While no evaluation resources appear to have been developed specifically for wearable 
devices, there are a number of evaluation frameworks and portals designed to aid clinicians in 
selecting appropriate mobile apps for mental health (Neary & Schueller, 2018), and these may be 
adopted for wearables too.  Research suggests that apps for anxiety disorders predominantly do 
not employ evidence-based components and the uptake of apps based directly on academic 
research is low (Bry, Chou, Miguel, & Comer, 2018; Neary & Schueller, 2018), necessitating 
proper evaluation of potential interventions.  At present, the PsyberGuide website 
(psyberguide.org) appears to be the only portal to list any wearable devices, with a review of the 
Muse headband.  Another approach is to use evaluation frameworks which provide structured 
guidelines for the systematic appraisal of mHealth technologies, and these frameworks can 
readily be applied to devices.  While some comprehensive scales have been developed to score 
technologies on a range of criteria (Baumel, Faber, Mathur, Kane, & Muench, 2017; Stoyanov et 
al., 2015), the American Psychiatric Association’s app evaluation model (American Psychiatric 
Association, 2017; Torous et al., 2018) is a briefer hierarchical framework that may be more 
suitable for clinical decision making, as it is used to weigh up apps qualitatively according to 
individual priorities.  Under this system, apps are subjected to a five-stage process beginning 
with the collection of background information, followed by the evaluation of risks, evidence, 
ease of use, and interoperability in turn (Figure 1).  Each stage of the assessment leads to a 
decision to proceed, to proceed with caution, or not to proceed.  This type of rapid evaluation 
may be useful in helping clinicians and clients orient to pertinent appraisal factors, instead of 
depending on unreliable information such as app store ratings and user reviews.  Where the use 
of technology is initiated by the clinician, this shared evaluation can also serve to adequately 
inform the client before consenting to treatment (Torous & Roberts, 2017). 
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Conclusion 
While there is strong and growing interest in wearable technologies for mental health 
disorders like anxiety, this interest has not yet catalysed sufficient research into the efficacy and 
effectiveness of such devices.  As with other mental health technologies, the introduction of 
wearable devices is bound to result in ongoing disruption in the way that treatments are 
delivered, at least for some.  Due to the broad subject of the present review, a narrative review 
approach was taken, limiting inferences that can be made about levels of evidence.  However, it 
was nonetheless apparent that overall, little evidence exists to support the use of specific devices 
for the treatment of anxiety disorders. This is perhaps due to the fact that technology is often 
superseded before it can be properly evaluated.  What evidence for specific devices could be 
identified here was also largely limited by methodological constraints and narrow or non-clinical 
samples, making the implications for the treatment of clinically significant anxiety symptoms in 
real-world clinical settings unclear.  Furthermore, general evidence for the modalities through 
which these devices are presumed to work also appears to be limited, though HRV biofeedback 
may be an exception to this.  Despite this general lack of evidence, it is advantageous for 
clinicians to be aware of common wearable devices and how they ostensibly function, since it is 
increasingly likely that clients may independently adopt such technologies.  However, the use of 
these devices as adjuncts should not supplant treatment with appropriate established therapies.  
Clinicians should be aware that there can be risks and unexpected effects resulting from the use 
of wearable devices.  Using clinical evaluation tools such as the APA app evaluation model to 
weigh up risks and benefits together with clients can help to identify anticipated problems, 
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ensure both client and practitioner are fully informed, and determine how devices will help work 
towards therapeutic goals. 
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Tables 
Table 1 
Summary of wearable devices with potential benefit for anxiety symptoms 
Modality Device Website Comments 
Approx. 
Cost 
EDA Pip (2014) 
Galvanic Ltd 
thepip.com Held between thumb and forefinger like a guitar 
plectrum; developer currently in liquidation. 
$245 AUD 
EEG Brainlink (2014) 
Macrotellect Ltd 
o.macrotellect.com 1 channel dry sensor headband €149 EUR 
 Insight (2015) 
Emotiv, Inc. 
emotiv.com 5 channel hybrid sensor headband (requires minimal 
priming with saline) 
$299 USD 
 Lowdown Focus (2017) 
SmithOptics, Inc. 
smithoptics.com EEG sunglasses based on Interaxon Muse technology 
(described below) 
$349 USD 
 Mindwave (2011) 
Neurosky, Inc. 
neurosky.com 1 channel dry sensor headband $79 USD 
 Muse (v2, 2016) 
Interaxon, Inc. 
choosemuse.com 4 channel dry sensor headband; primarily offers aided 
meditation but third-party apps can be used also 
$249 USD 
 Myndband (2016) 
Myndplay Ltd 
myndplay.com 1 channel dry sensor headband £179 GBP 
 SenzeBand (2016) 
Neeuro Pte Ltd 
neeuro.com 4 channel dry sensor headband $299 USD 
Entrainment Doppel (2018) 
Team Turquoise Ltd 
feeldoppel.com Worn on inside of wrist where the pulse is normally 
felt; provides a regular heartbeat-like tactile sensation 
$179 USD 
HRV† emWave 2 (2011) 
HeartMath, Inc. 
heartmath.com Standalone feedback device or used with apps on Mac 
or Windows (no smartphone support) 
$199 USD 
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Modality Device Website Comments 
Approx. 
Cost 
 Blaze, Charge 2, Ionic, 
Versa 
FitBit, Inc. 
fitbit.com ‘Relax’ app guides breathing based on HRV patterns $119- 
$249 USD 
 Inner Balance (2013) 
HeartMath, Inc. 
heartmath.com Bluetooth or wired sensor worn on the earlobe during 
biofeedback sessions 
$159 USD 
 Sona (2015) 
Caeden, Inc. 
caeden.com Wristband; monitors HRV through the day and offers 
HRV biofeedback sessions 
$199 USD 
Respiration Stone (2014) 
Spire, Inc. 
spire.io Sensor worn on belt or bra; feedback on elevated and 
calm states in realtime; also short biofeedback sessions 
$149 USD 
Note: † The products listed here are integrated software and hardware HRV solutions.  However, a range of smartphone apps can also 
be linked to low-cost generic sensor devices (chest strap, ear clip, finger clip and a limited range of smart watch devices) to provide 
session-based HRV biofeedback.  
